No Detail Found!

Concurrent Cisplatin-based Chemoradiation in Squamous Cell Carcinoma of Cervix.

Author(s)
Hina Hashmi Department of Clinical Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), Karachi, Pakistan
Amir Maqbool Department of Clinical Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), Karachi, Pakistan
Saeed Ahmed Department of Clinical Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), Karachi, Pakistan
Adeel Ahmed Department of Clinical Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), Karachi, Pakistan
Kulsoom Sheikh Department of Clinical Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), Karachi, Pakistan
Akhtar Ahmed Department of Nuclear Medicine, Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), Karachi, Pakistan
Abstract
Objective: To evaluate the efficacy of cisplatin-based concurrent chemoradiation in squamous cell carcinoma of cervix and the frequency of acute toxicity. Study Design: Case series. Place and Duration of Study: Department of Clinical Oncology, Karachi Institute of Radiotherapy and Nuclear Medicine (KIRAN), Karachi, from September 2010 to September 2011. Methodology: Eighty patients with histologically proven squamous cell carcinoma of cervix were included. Patients were treated with concurrent chemoradiation. External beam radiation was delivered with 50 Gy whole pelvis along with 40 mg/m2 weekly cisplatin followed by brachytherapy three insertions of 6.5 Gy each, one week apart. Response to treatment was assessed using response evaluation criteria in solid tumours (RECIST) criteria at 4 weeks after treatment. Acute toxicity of chemoradiation was assessed using common toxicity criteria. Results: Out of the 80 patients, 8 patients were lost to follow-up. Remaining 72 patients aged 28 - 65 years with mean age of 48.03 ±8.9 years. Forty-eight patients (66%) were in stage II-B, 5 (7%) were in stage III-A, 7 (10%) were in stage III-B, and 12 (17%) were in stage IV-A. Overall response to treatment was 92%, in which 39 (54%) had complete response, and 27 (38%) had partial response while 6 (8%) show progressive disease. About 70% patients had diarrhea, 61.2% patients developed vomiting, 45.8% patients had dermatitis, 43% patients had vaginal mucositis, 40.3% had anemia, 13.9% patients had neutropenia, 27.8% patients had dysuria, and 22.2% patients had proctitis. Conclusion: Cisplatin-based concurrent chemoradiation is an effective treatment in locally advanced stage of cervical cancer with manageable toxicity.
Publication Details
Page(s) 302-305
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 4, Year: 2016

Request the full text from PASTIC

References
MonkBJ,TewariKS,KohWJ, 2007.Multimodality therapy for locally advanced cervical carcinoma: state of art and future direction,J Clin Oncol 25 2952 -65
HanifM,ZaidiP,KamalS,HameedA, 2009.Institution-based cancer incidence in a local population in Pakistan: nine-year data analysis,Asian Pacific J Cancer Prev 10 1 -4
ParveenS,SajjadR,MasoodM,AnzarH,YunusN,AsgharS., 2006.Cervical cancer: outcome of treatment and causes of failure,J Pak Med Assoc 56 436 -40
RosePG,BundyBN,WatkinsEB,ThigpenJT,DeppeG,MaimanMA, 1999.Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer,N Engl J Med 15 1143 -53
KeysHM,BundyBN,StehmanFB,MuderspachLI,ChafeWE,SuggsCL, 1999.Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma,N Engl J Med 340 1154 -61
MorrisM,EifelPJ,LuJ, 1999.Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high- risk cervical cancer,N Engl J Med 340 1137 -43
PetersWA,LiuPY,BarrettRJ, 2000.Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix,J Clin Oncol 18 1606 -13
WhitneyCW,SauseW,BundyBN,MalfetanoJH,HanniganE,FowlerWC, 1999.Randomized comparison of fluorouracil plus cisplatin vs. hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study,J Clin Oncol 17 1339 -48
PearcyR,MiaoQ,KongW,Zhang-SalomonsJ,WilliamJ, 2007.Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population based cohort study,J Clin Oncol 25 2383 -8
Shaharyar,ShamiN,AlauddinZ,MahmoodA,MahmoodI,ChaudharyM, 2000.Results of radiotherapy and concomitant cisplatin in locally advanced squamous cell carcinoma of uterine cervix,Ann King Edward Med Coll 6 230 -3
FarrukhM., 1999.Role of brachytherapy in uterine cervix carcinoma,J Coll Physician Surg Pak 9 24 -7
RobertsKB1,UrdanetaN,VeraR,VeraA,GutierrezE,AguilarY, 2000.Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix,Int J Cancer 90 206 -23
StehmanFB,BundyBN,ThomasG, 1993.Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial,J Clin Oncol 11 1523 -8
1999.Clinical announcement. Concurrent chemoradiation for cervical cancer, -
AlbertsDS,Mason-LiddilN., 1989.The role of cisplatin in the management of advanced squamous cell cancer of the cervix,Semin Oncol 16 66 -78
DupontNC,MonkBJ, 2006.Chemotherapy in the management of cervical carcinoma,Clin Ad Hematol Oncol 4 279 -83
SinghTT,SinghIY,SharmaDT,SinghN., 2003.Role of chemoradiation in advanced cervical cancer,Indian J Cancer 40 101 -7
NegiRR,GuptaM,KumarM,GuptaMK,SeamR,RastogiM., 2010.Concurrent chemoradiation in locally advanced carcinoma cervix patients,J Can Res Ther 6 159 -66
PearcyRG,MacLean GD, 1992.A phase I /II study combining radical radiotherapy with concurrent cisplatin in the treatment of advanced squamous-cell carcinoma of the cervix,J Gynecol Cancer 2 215 -9
KunduS,BasuS,AcharyaS,DastidarAG,RoyA, 2008.Chemoradiation in locally advanced cervical cancer: a randomized trial,Indian J Med Paediatr Oncol 29 12 -8
OzsaranZ,YalmanD,YürütV,ArasA,OzsaranA,HanhanM, 2003.Radiochemotherapy for patients with locally advanced cervical cancer: early results,Eur J Gynaecol Oncol 24 191 -4
2008.Chemoradiotherapy for cervical cancer meta-analysis collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials,J Clin Oncol 26 5802 -12
GreenJA,KirwanJJ,TierneyJ,ValeCL,SymondsPR,FrescoLL, 2010.Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix,Cochrane Database Sysy Rev CD002225 -
0

Citations

0

Downloads

143

Views